Science and Research

Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma

This study of the eosinophil cationic protein (ECP) as predictor of clinical response to biological therapy in severe asthma found that ECP is not useful in unselected patients but may have a role in those not exposed to oral corticosteroids. https://bit.ly/398RwEk.

  • Franceschi, E.
  • Drick, N.
  • Fuge, J.
  • Welte, T.
  • Suhling, H.
Publication details
DOI: 10.1183/23120541.00138-2022
Journal: ERJ Open Res
Number: 3
Work Type: Original
Location: BREATH
Disease Area: AA
Partner / Member: MHH
Access-Number: 36171986

DZL Engagements

chevron-down